A detailed history of Creative Planning transactions in Organon & Co. stock. As of the latest transaction made, Creative Planning holds 83,684 shares of OGN stock, worth $1.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
83,684
Previous 83,594 0.11%
Holding current value
$1.26 Million
Previous $1.73 Million 7.51%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$18.65 - $23.03 $1,678 - $2,072
90 Added 0.11%
83,684 $1.6 Million
Q2 2024

Aug 15, 2024

SELL
$17.45 - $21.96 $4,728 - $5,951
-271 Reduced 0.32%
83,594 $1.73 Million
Q1 2024

May 10, 2024

BUY
$13.78 - $18.8 $41,271 - $56,306
2,995 Added 3.7%
83,865 $1.58 Million
Q4 2023

Feb 14, 2024

BUY
$10.95 - $17.32 $460,064 - $727,699
42,015 Added 108.13%
80,870 $1.17 Million
Q3 2023

Nov 16, 2023

BUY
$16.59 - $23.77 $63,722 - $91,300
3,841 Added 10.97%
38,855 $674,000
Q2 2023

Jul 21, 2023

SELL
$19.27 - $24.63 $75,557 - $96,574
-3,921 Reduced 10.07%
35,014 $728,000
Q1 2023

May 15, 2023

BUY
$21.42 - $32.08 $50,551 - $75,708
2,360 Added 6.45%
38,935 $915,000
Q4 2022

Feb 10, 2023

SELL
$23.31 - $28.61 $35,710 - $43,830
-1,532 Reduced 4.02%
36,575 $1.02 Million
Q3 2022

Nov 03, 2022

BUY
$23.4 - $34.25 $18,415 - $26,954
787 Added 2.11%
38,107 $892,000
Q2 2022

Aug 15, 2022

SELL
$31.66 - $38.9 $46,571 - $57,221
-1,471 Reduced 3.79%
37,320 $1.26 Million
Q1 2022

May 16, 2022

SELL
$30.45 - $39.36 $8,800 - $11,375
-289 Reduced 0.74%
38,791 $1.36 Million
Q4 2021

Feb 11, 2022

SELL
$28.67 - $37.13 $2.75 Million - $3.56 Million
-95,942 Reduced 71.06%
39,080 $1.19 Million
Q3 2021

Nov 10, 2021

BUY
$28.63 - $35.64 $696,625 - $867,192
24,332 Added 21.98%
135,022 $4.43 Million
Q2 2021

Aug 04, 2021

BUY
$28.45 - $38.0 $3.15 Million - $4.21 Million
110,690 New
110,690 $3.35 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.82B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.